رجوع
نطاق اليوم
KWD 103.11
KWD 107.92
نطاق 52 أسبوعًا
KWD 100.18
KWD 143.32
حجم التداول
685,434
متوسط 50 يوم / 200 يوم
KWD 108.90
/
KWD 118.14
الإغلاق السابق
KWD 105.85
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -5.2 | 0.4 |
| P/B | 1.5 | 2.9 |
| ROE % | -24.5 | 3.7 |
| Net Margin % | -45.5 | 3.9 |
| Rev Growth 5Y % | -8.2 | 10.0 |
| D/E | 0.9 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 133.250
+25.0%
Low: KWD 116.000
High: KWD 147.000
مكرر الربحية المستقبلي
14.3
ربحية السهم المستقبلية
KWD 7.428
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
2.4 B
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 11.070
KWD 10.997 – KWD 11.166
|
2.8 B | 1 |
| FY2029 |
KWD 10.040
KWD 9.974 – KWD 10.127
|
2.7 B | 1 |
| FY2028 |
KWD 11.757
KWD 11.679 – KWD 11.859
|
2.5 B | 1 |
النقاط الرئيسية
Revenue declined -8.23% annually over 5 years
Earnings declined -1399.81% over the past year
Generating 245.44M in free cash flow
PEG of 0.00 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 26.38%
Capital efficient — spends only 4.78% of revenue on capex
النمو
Revenue Growth (5Y)
-8.23%
Revenue (1Y)-34.61%
Earnings (1Y)-1399.81%
FCF Growth (3Y)-23.48%
الجودة
Return on Equity
-24.47%
ROIC3.28%
Net Margin-45.45%
Op. Margin12.84%
الأمان
Debt / Equity
0.87
Current Ratio2.54
Interest Coverage2.55
التقييم
P/E Ratio
-5.20
P/B Ratio1.51
EV/EBITDA27.53
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -34.61% | Revenue Growth (3Y) | -18.15% |
| Earnings Growth (1Y) | -1399.81% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -8.23% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1.99B | Net Income (TTM) | -905.64M |
| ROE | -24.47% | ROA | -13.04% |
| Gross Margin | 56.24% | Operating Margin | 12.84% |
| Net Margin | -45.45% | Free Cash Flow (TTM) | 245.44M |
| ROIC | 3.28% | FCF Growth (3Y) | -23.48% |
| Safety | |||
| Debt / Equity | 0.87 | Current Ratio | 2.54 |
| Interest Coverage | 2.55 | Dividend Yield | 0.01% |
| Valuation | |||
| P/E Ratio | -5.20 | P/B Ratio | 1.51 |
| P/S Ratio | 2.36 | PEG Ratio | 0.00 |
| EV/EBITDA | 27.53 | Dividend Yield | 0.01% |
| Market Cap | 4.71B | Enterprise Value | 7.04B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.99B | 3.05B | 2.97B | 2.79B | 2.81B |
| Net Income | -905.64M | 69.68M | 356.33M | 363.14M | 485.37M |
| EPS (Diluted) | -20.25 | 1.48 | 7.53 | 7.68 | 10.23 |
| Gross Profit | 1.12B | 1.70B | 1.65B | 1.53B | 1.55B |
| Operating Income | 255.80M | 151.01M | 506.31M | 499.73M | 628.10M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 6.95B | 7.10B | 7.53B | 6.93B | 6.87B |
| Total Liabilities | 3.82B | 2.82B | 3.09B | 2.91B | 3.12B |
| Shareholders' Equity | 3.12B | 4.28B | 4.44B | 4.02B | 3.75B |
| Total Debt | 2.73B | 1.76B | 1.93B | 1.83B | 1.97B |
| Cash & Equivalents | 393.26M | 290.19M | 222.85M | 292.03M | 445.08M |
| Current Assets | 1.94B | 1.47B | 1.41B | 1.41B | 1.43B |
| Current Liabilities | 762.03M | 649.36M | 606.75M | 581.49M | 680.12M |